Literature DB >> 2508084

Serotonin and treatment in obsessive-compulsive disorder.

J S March1, L D Gutzman, J W Jefferson, J H Greist.   

Abstract

Recognized since the Middle Ages, and clearly described for more than 100 years, obsessive-compulsive disorder (OCD) continues to intrigue and challenge mental health professionals. Recent evidence has implicated dysfunctional serotonergic neurotransmission in OCD. This review summarizes the evidence favoring a serotonergic hypothesis for OCD followed by a more detailed discussion of the implications the hypothesis holds for treatment.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2508084

Source DB:  PubMed          Journal:  Psychiatr Dev        ISSN: 0262-9283


  3 in total

Review 1.  Categorical and unitary classification of neurotic disorder.

Authors:  M Roth
Journal:  J R Soc Med       Date:  1990-10       Impact factor: 18.000

Review 2.  The Neuronal Glutamate Transporter EAAT3 in Obsessive-Compulsive Disorder.

Authors:  Angélica P Escobar; Jens R Wendland; Andrés E Chávez; Pablo R Moya
Journal:  Front Pharmacol       Date:  2019-11-15       Impact factor: 5.810

Review 3.  The neurobiological link between OCD and ADHD.

Authors:  Silvia Brem; Edna Grünblatt; Renate Drechsler; Peter Riederer; Susanne Walitza
Journal:  Atten Defic Hyperact Disord       Date:  2014-07-14
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.